Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein

Veterinary Microbiology

Volumn 136, Issue 1-2, 2009, Pages 155-159

  Mizukoshi, Fuminori ^a   Baba, Kenji ^a   Goto, Yuko ^a   Setoguchi, Asuka ^a   Fujino, Yasuhito ^a   Ohno, Koichi ^a   Oishi, Shinya ^b   Kodera, Yasuyo ^b   Fujii, Nobutaka ^b   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

gp40; Lentivirus; Membrane fusion inhibitor

Indexed keywords

MEMBRANE FUSION PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN FIV C35; VIRUS ENVELOPE PROTEIN FIV C35EK1; VIRUS ENVELOPE PROTEIN FIV C35EK2; VIRUS ENVELOPE PROTEIN FIV C35EK3; VIRUS ENVELOPE PROTEIN FIV N36; VIRUS ENVELOPE PROTEIN GP40;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DOMAIN; VIRUS ENVELOPE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GIANT CELLS; GLYCOPROTEINS; HELA CELLS; HISTOCYTOCHEMISTRY; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

FELINE IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

EID: 62749156807     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.10.009     Document Type: Article

References (12)

1. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., and Tozzini F. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8 (1995) 87-112
2. Eckert D.M., and Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70 (2001) 777-810
3. Endo Y., Goto Y., Nishimura Y., Mizuno T., Watari T., Hasegawa A., Hohdatsu T., Koyama H., and Tsujimoto H. Inhibitory effect of stromal cell derived factor-1 on the replication of divergent strains of feline immunodeficiency virus in a feline T-lymphoid cell line. Vet. Immunol. Immunopathol. 74 (2000) 303-314
4. Garg H., Fuller F.J., and Tompkins W.A. Mechanism of feline immunodeficiency virus envelope glycoprotein-mediated fusion. Virology 321 (2004) 274-286
5. Kakinuma S., Motokawa K., Hohdatsu T., Yamamoto J.K., Koyama H., and Hashimoto H. Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes. J. Virol. 69 (1995) 3639-3646
6. Medinas R.J., Lambert D.M., and Tompkins W.A. C-terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. J. Virol. 76 (2002) 9079-9086
7. Miyazawa T., Furuya T., Itagaki S., Tohya Y., Takahashi E., and Mikami T. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108 (1989) 131-135
8. Nishimura Y., Goto Y., Pang H., Endo Y., Mizuno T., Momoi Y., Watari T., Tsujimoto H., and Hasegawa A. Genetic heterogeneity of env gene of feline immunodeficiency virus obtained from multiple districts in Japan. Virus Res. 57 (1998) 101-112
9. Otaka A., Nakamura M., Nameki D., Kodama E., Uchiyama S., Nakamura S., Nakano H., Tamamura H., Kobayashi Y., Matsuoka M., and Fujii N. Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells. Angew. Chem. Int. Ed. Engl. 41 (2002) 2937-2940
10. Rigby M.A., Holmes E.C., Pistello M., Mackay A., Brown A.J., and Neil J.C. Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J. Gen. Virol. 74 (1993) 425-436
11. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., and Matthews T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9770-9774
12. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., and Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71 (1997) 6407-6415